Capital Fund Management S.A. Sells 8,990 Shares of Cardinal Health, Inc. $CAH

Key Points

• Capital Fund Management S.A. has reduced its stake in Cardinal Health, Inc. by selling 8,990 shares, bringing their total ownership to approximately 143,103 shares worth $19,715,000.
• Institutional investors now hold 87.17% of Cardinal Health’s shares, with significant increases in holdings from firms like Principal Financial Group Inc. and Kingswood Wealth Advisors LLC.
• Cardinal Health recently announced a quarterly dividend of $0.5107 per share, which represents a 1.3% dividend yield based on an annualized rate of $2.04.

Capital Fund Management S.A. decreased its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 5.9% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 143,103 shares of the company's stock after selling 8,990 shares during the quarter. Capital Fund Management S.A. owned approximately 0.06% of Cardinal Health worth $19,715,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the business. JPMorgan Chase & Co. raised its position in Cardinal Health by 40.0% in the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company's stock valued at $575,327,000 after purchasing an additional 1,193,983 shares during the last quarter. Northern Trust Corp raised its position in Cardinal Health by 3.5% in the 1st quarter. Northern Trust Corp now owns 3,143,003 shares of the company's stock valued at $433,012,000 after purchasing an additional 105,154 shares during the last quarter. Wellington Management Group LLP raised its position in Cardinal Health by 1,666.7% in the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company's stock valued at $328,470,000 after purchasing an additional 2,249,241 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Cardinal Health by 4.3% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,321,797 shares of the company's stock valued at $274,599,000 after purchasing an additional 94,768 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD raised its position in Cardinal Health by 3.6% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 1,601,322 shares of the company's stock valued at $189,390,000 after purchasing an additional 55,781 shares during the last quarter. Institutional investors own 87.17% of the company's stock.

Cardinal Health Price Performance

Shares of NYSE CAH traded down $3.5270 during midday trading on Friday, hitting $148.0430. The stock had a trading volume of 2,685,985 shares, compared to its average volume of 2,527,078. Cardinal Health, Inc. has a fifty-two week low of $106.54 and a fifty-two week high of $168.44. The company's 50-day simple moving average is $159.02 and its 200 day simple moving average is $145.45. The firm has a market cap of $35.35 billion, a P/E ratio of 22.95, a price-to-earnings-growth ratio of 1.25 and a beta of 0.67.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping analysts' consensus estimates of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business had revenue of $60.16 billion during the quarter, compared to analysts' expectations of $60.91 billion. During the same period in the previous year, the firm earned $1.84 earnings per share. The firm's quarterly revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be paid a dividend of $0.5107 per share. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.4%. Cardinal Health's payout ratio is 31.63%.

Insider Buying and Selling at Cardinal Health

In related news, insider Ola M. Snow sold 28,151 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the completion of the sale, the insider directly owned 15,431 shares of the company's stock, valued at $2,298,293.14. The trade was a 64.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Stephen M. Mason sold 41,575 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $6,187,191.50. Following the sale, the chief executive officer directly owned 26,085 shares of the company's stock, valued at approximately $3,881,969.70. This trade represents a 61.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 271,676 shares of company stock valued at $40,489,525 over the last quarter. 0.09% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

CAH has been the subject of several research analyst reports. UBS Group reiterated a "buy" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Wells Fargo & Company reissued an "overweight" rating and issued a $185.00 target price (up from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Jefferies Financial Group set a $150.00 target price on Cardinal Health in a research note on Tuesday, August 12th. Robert W. Baird lifted their target price on Cardinal Health from $197.00 to $203.00 and gave the company an "outperform" rating in a research note on Wednesday, August 13th. Finally, Leerink Partners lowered their target price on Cardinal Health from $188.00 to $186.00 and set an "outperform" rating for the company in a research note on Tuesday, August 12th. Twelve analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $163.20.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.